Home » Topics » BioWorld Science

BioWorld Science
RSS

AD-452 enters phase IIa study for rheumatoid arthritis

June 14, 2004

Preliminary results from phase II Liprostin trial in peripheral vascular disease

June 14, 2004

Metabolic offers progress report

June 14, 2004

Eloxatin awarded 2004 Prix Galien in France

June 14, 2004

Positive opinion for Apidra in E.U.

June 14, 2004

VX-950 enters phase I for HCV

June 14, 2004

Cytomodulin promotes collagen transcription and wound healing in mice

June 14, 2004

Novel atrial K+ channel blockers for prevention of recurrence of atrial fibrillation

June 14, 2004

5-HT2a inverse agonists for the treatment of sleep disorders

June 14, 2004

Eszopiclone for insomnia subject of several studies presented at sleep conference

June 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...